Regular exercise, particularly progressive resistance training (PRT), is recognized as one of the most effective strategies to prevent age-related muscle loss (sarcopenia), but its effects on muscle function are mixed. However, emerging data indicates that high velocity PRT (fast concentric muscle contractions) is more effective for improving functional outcomes than traditional PRT. In terms of falls prevention, high-challenging balance training programs appear to be most effective. There is also compelling evidence that supplemental vitamin D is an effective therapeutic option for falls prevention. The findings from a recent meta-analysis revealed that supplemental vitamin D at a dose of at least 700–1,000 IU/d or an achieved serum 25(OH)D level of at least 60 nmol/L was associated with reduced falls risk among older individuals. Based on these findings, it is possible that the combination of exercise and vitamin D could have a synergistic effect on muscle morphology and function, particularly since both interventions have been shown to have beneficial effects on type II “fast twitch” muscle fibers and systemic inflammation, which have both been linked to losses in muscle mass and function. Unfortunately however, the findings from the limited number of factorial 2 × 2 design RCTs indicate that additional vitamin D does not enhance the effects of exercise on measures of muscle morphology, function or falls risk. However, none of these trials were adequately powered to detect a “synergistic” effect between the two treatment strategies, but it is likely that if an exercise-by-vitamin D interaction does exist, it may be limited to situations when vitamin D deficiency/insufficiency is corrected. Further targeted research in “high risk” groups is still needed to address this question, and evaluate whether there is a threshold level of serum 25(OH)D to maximize the effects of exercise on muscle and falls risk.
References
[1]
Doherty, T. Invited review: Aging and sarcopenia. J. Appl. Physiol.？2003, 95, 1717–1727.
[2]
Janssen, I.; Heymsfield, S.B.; Wang, Z.M.; Ross, R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J. Appl. Physiol.？2000, 89, 81–88.
[3]
Gallagher, D.; Visser, M.; De Meersman, R.E.; Sepulveda, D.; Baumgartner, R.N.; Pierson, R.N.; Harris, T.; Heymsfield, S.B. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J. Appl. Physiol.？1997, 83, 229–239. 9216968
[4]
Deschenes, M.R. Effects of aging on muscle fibre type and size. Sports Med.？2004, 34, 809–824.
[5]
Larsson, L.; Grimby, G.; Karlsson, J. Muscle strength and speed of movement in relation to age and muscle morphology. J. Appl. Physiol.？1979, 46, 451–456.
[6]
Lindle, R.S.; Metter, E.J.; Lynch, N.A.; Fleg, J.L.; Fozard, J.L.; Tobin, J.; Roy, T.A.; Hurley, B.F. Age and gender comparisons of muscle strength in 654 women and men aged 20–93 yr. J. Appl. Physiol.？1997, 83, 1581–1587.
[7]
Hughes, V.A.; Frontera, W.R.; Wood, M.; Evans, W.J.; Dallal, G.E.; Roubenoff, R.; Fiatarone Singh, M.A. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J. Gerontol. A Biol. Sci. Med. Sci.？2001, 56, B209–B217.
[8]
Frontera, W.R.; Hughes, V.A.; Fielding, R.A.; Fiatarone, M.A.; Evans, W.J.; Roubenoff, R. Aging of skeletal muscle: a 12-yr longitudinal study. J. Appl. Physiol.？2000, 88, 1321–1326.
[9]
Murray, M.P.; Duthie, E.H.J.; Gambert, S.R.; Sepic, S.B.; Mollinger, L.A. Age-related differences in knee muscle strength in normal women. J. Gerontol.？1985, 40, 275–280.
[10]
Lexell, J.; Taylor, C.C.; Sjostrom, M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J. Neurol. Sci.？1988, 84, 275–294.
[11]
Bassey, E.J.; Fiatarone, M.A.; O’Neill, E.F.; Kelly, M.; Evans, W.J.; Lipsitz, L.A. Leg extensor power and functional performance in very old men and women. Clin. Sci. (Lond.)？1992, 82, 321–327. 1312417
[12]
Foldvari, M.; Clark, M.; Laviolette, L.C.; Bernstein, M.A.; Kaliton, D.; Castaneda, C.; Pu, C.T.; Hausdorff, J.M.; Fielding, R.A.; Singh, M.A. Association of muscle power with functional status in community-dwelling elderly women. J. Gerontol. A Biol. Sci. Med. Sci.？2000, 55, M192–M199.
[13]
Skelton, D.A.; Kennedy, J.; Rutherford, O.M. Explosive power and asymmetry in leg muscle function in frequent fallers and non-fallers aged over 65. Age Ageing？2002, 31, 119–125.
[14]
Daynes, R.A.; Araneo, B.A.; Ershler, W.B.; Maloney, C.; Li, G.Z.; Ryu, S.Y. Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J. Immunol.？1993, 150, 5219–5230. 8515056
[15]
Tracy, R.P. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int. J. Obes. Relat. Metab. Disord.？2003, 27, S29–S34.
[16]
Janssen, I.; Ross, R. Linking age-related changes in skeletal muscle mass and composition with metabolism and disease. J. Nutr. Health Aging？2005, 9, 408–419.
[17]
Schaap, L.A.; Pluijm, S.M.; Deeg, D.J.; Visser, M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am. J. Med.？2006, 119, 526.e9–526.e17.
[18]
Ferrucci, L.; Penninx, B.W.J.H.; Volpato, S.; Harris, T.B.; Bandeen-Roche, K.; Balfour, J.; Leveille, S.G.; Fried, L.P.; Guralnik, J.M. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J. Am. Geriatr. Soc.？2002, 50, 1947–1954.
[19]
Ferrucci, L.; Harris, T.B.; Guralnik, J.M.; Tracy, R.P.; Corti, M.C.; Cohen, H.J.; Penninx, B.; Pahor, M.; Wallace, R.; Havlik, R.J. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc.？1999, 47, 639–646.
[20]
Steib, S.; Schoene, D.; Pfeifer, K. Dose-response relationship of resistance training in older adults: a meta-analysis. Med. Sci. Sports Exerc.？2010, 42, 902–914.
[21]
Charette, S.L.; McEvoy, L.; Pyka, G.; Snow-Harter, C.; Guido, D.; Wiswell, R.A.; Marcus, R. Muscle hypertrophy response to resistance training in older women. J. Appl. Physiol.？1991, 70, 1912–1916.
[22]
Frontera, W.R.; Meredith, C.N.; O’Reilly, K.P.; Knuttgen, H.G.; Evans, W.J. Strength conditioning in older men: skeletal muscle hypertrophy and improved function. J. Appl. Physiol.？1988, 64, 1038–1044.
[23]
Fiatarone, M.A.; O’Neill, E.F.; Ryan, N.D.; Clements, K.M.; Solares, G.R.; Nelson, M.E.; Roberts, S.B.; Kehayias, J.J.; Lipsitz, L.A.; Evans, W.J. Exercise training and nutritional supplementation for physical frailty in very elderly people. N. Engl. J. Med.？1994, 330, 1769–1775.
[24]
Latham, N.K.; Bennett, D.A.; Stretton, C.M.; Anderson, C.S. Systematic review of progressive resistance strength training in older adults. J. Gerontol. A Biol. Sci. Med. Sci.？2004, 59, 48–61.
[25]
Liu, C.J.; Latham, N.K. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst. Rev.？2009, CD002759.
[26]
Aagaard, P.; Simonsen, E.B.; Andersen, J.L.; Magnusson, P.; Dyhre-Poulsen, P. Increased rate of force development and neural drive of human skeletal muscle following resistance training. J. Appl. Physiol.？2002, 93, 1318–1326.
[27]
Sayers, S.P. High-speed power training: a novel approach to resistance training in older men and women. A brief review and pilot study. J. Strength Cond. Res.？2007, 21, 518–526. 17530980
[28]
Sherrington, C.; Whitney, J.C.; Lord, S.R.; Herbert, R.D.; Cumming, R.G.; Close, J.C. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J. Am. Geriatr. Soc.？2008, 56, 2234–2243.
Glerup, H.; Mikkelsen, K.; Poulsen, L.; Hass, E.; Overbeck, S.; Andersen, H.; Charles, P.; Eriksen, E.F. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif. Tissue Int.？2000, 66, 419–424.
[31]
Bischoff-Ferrari, H.A.; Borchers, M.; Gudat, F.; Durmuller, U.; Stahelin, H.B.; Dick, W. Vitamin D receptor expression in human muscle tissue decreases with age. J. Bone Miner. Res.？2004, 19, 265–269. 14969396
[32]
Wicherts, I.S.; van Schoor, N.M.; Boeke, A.J.; Visser, M.; Deeg, D.J.; Smit, J.; Knol, D.L.; Lips, P. Vitamin D status predicts physical performance and its decline in older persons. J. Clin. Endocrinol. Metab.？2007, 92, 2058–2065.
[33]
Visser, M.; Deeg, D.J.; Lips, P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The longitudinal aging study Amsterdam. J. Clin. Endocrinol. Metab.？2003, 88, 5766–5772.
[34]
Sato, Y.; Iwamoto, J.; Kanoko, T.; Satoh, K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc. Dis.？2005, 20, 187–192.
[35]
Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Staehelin, H.B.; Orav, J.E.; Stuck, A.E.; Theiler, R.; Wong, J.B.; Egli, A.; Kiel, D.P.; Henschkowski, J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ？2009, 339, b3692.
[36]
Latham, N.K.; Anderson, C.S.; Reid, I.R. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J. Am. Geriatr. Soc.？2003, 51, 1219–1226.
[37]
Broe, K.E.; Chen, T.C.; Weinberg, J.; Bischoff-Ferrari, H.A.; Holick, M.F.; Kiel, D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J. Am. Geriatr. Soc.？2007, 55, 234–239.
[38]
Sorensen, O.H; Lund, B.; Saltin, B.; Andersen, R.B.; Hjorth, L.; Melsen, F.; Mosekilde, L. Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin. Sci. (Lond.)？1979, 56, 157–161. 477197
[39]
Van den Berghe, G.; Van Roosbroeck, D.; Vanhove, P.; Wouters, P.J.; De Pourcq, L.; Bouillon, R. Bone turnover in prolonged critical illness: effect of vitamin D. J. Clin. Endocrinol. Metab.？2003, 88, 4623–4632.
[40]
Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr.？2006, 83, 754–759. 16600924
[41]
Zittermann, A.; Dembinski, J.; Stehle, P. Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr. Allergy Immunol.？2004, 15, 242–246.
[42]
Sambrook, P.N.; Chen, J.S.; March, L.M.; Cameron, I.D.; Cumming, R.G.; Lord, S.R.; Zochling, J.; Sitoh, Y.Y.; Lau, T.C.; Schwarz, J.; Seibel, M.J. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J. Clin. Endocrinol. Metab.？2004, 89, 1572–1576.
[43]
Mitnick, M.A.; Grey, A.; Masiukiewicz, U.; Bartkiewicz, M.; Rios-Velez, L.; Friedman, S.; Xu, L.; Horowitz, M.C.; Insogna, K. Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am. J. Physiol. Endocrinol. Metab.？2001, 280, E405–E412.
[44]
Visser, M.; Pahor, M.; Taaffe, D.R.; Goodpaster, B.H.; Simonsick, E.M.; Newman, A.B.; Nevitt, M.; Harris, T.B. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci.？2002, 57, M326–M332.
[45]
Joborn, C.; Joborn, H.; Rastad, J.; Akerstrom, G.; Ljunghall, S. Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br. J. Surg.？1988, 75, 77–80.
[46]
Gallagher, J.C.; Rapuri, P.; Smith, L. Falls are associated with decreased renal function and insufficient calcitriol production by the kidney. J. Steroid Biochem. Mol. Biol.？2007, 103, 610–613.
[47]
Dukas, L.; Schacht, E.; Stahelin, H.B. In elderly men and women treated for osteoporosis a low creatinine clearance of <65 mL/min is a risk factor for falls and fractures. Osteoporos. Int.？2005, 16, 1683–1690.
[48]
Dukas, L.C.; Schacht, E.; Mazor, Z.; Stahelin, H.B. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 mL/min. Osteoporos. Int.？2005, 16, 332–338.
[49]
Dukas, L.; Bischoff, H.A.; Lindpaintner, L.S.; Schacht, E.; Birkner-Binder, D.; Damm, T.N.; Thalmann, B.; Stahelin, H.B. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J. Am. Geriatr. Soc.？2004, 52, 230–236.
[50]
Gallagher, J.C.; Fowler, S.E.; Detter, J.R.; Sherman, S.S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J. Clin. Endocrinol. Metab.？2001, 86, 3618–3628.
[51]
Sanders, K.M.; Stuart, A.L.; Williamson, E.J.; Simpson, J.A.; Kotowicz, M.A.; Young, D.; Nicholson, G.C. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA？2010, 303, 1815–1822.
[52]
Bunout, D.; Barrera, G.; Leiva, L.; Gattas, V.; Pia de la Maza, M.; Avendano, M.; Hirsch, R. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp. Gerontol.？2006, 41, 746–752.
[53]
Kukuljan, S.; Nowson, C.A.; Sanders, K.; Daly, R.M. Effects of resistance exercise and fortified milk on skeletal muscle mass, muscle size, and functional performance in middle-aged and older men: an 18-mo randomized controlled trial. J. Appl. Physiol.？2009, 107, 1864–1873, doi:10.1152/japplphysiol.00392.2009. 19850735
[54]
Bischoff-Ferrari, H.A.; Dawson-Hughes, B.; Platz, A.; Orav, E.J.; Stahelin, H.B.; Willett, W.C.; Can, U.; Egli, A.; Mueller, N.J.; Looser, S.; Bretscher, B.; Minder, E.; Vergopoulos, A.; Theiler, R. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch. Intern. Med.？2010, 170, 813–820.
[55]
Okuno, J.; Tomura, S.; Yabushita, N.; Kim, M.J.; Okura, T.; Tanaka, K.; Yanagi, H. Effects of serum 25-hydroxyvitamin D(3) levels on physical fitness in community-dwelling frail women. Arch. Gerontol. Geriatr.？2010, 50, 121–126.
